{"id":"W4402128677","doi":"10.1038/s41568-024-00737-z","title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","year":2024,"lang":"en","type":"review","venue":"Nature reviews. Cancer","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Congressionally Directed Medical Research Programs; National Cancer Institute; West China Hospital, Sichuan University; Rosetrees Trust; National Institutes of Health; Coral Reef Conservation Program; Medical Research Council; Astex Pharmaceuticals; Sichuan University; Krebsliga Schweiz; Canadian Institutes of Health Research; Fonds Wetenschappelijk Onderzoek; Genentech; National Natural Science Foundation of China; Associazione Italiana per la Ricerca sul Cancro; U.S. Department of Defense; European Commission; Wellcome Trust; KWF Kankerbestrijding; Cancer Research UK; Revolution Medicines; KU Leuven; Incyte; National Institute on Aging; Melanoma Research Alliance; Agència de Gestió d'Ajuts Universitaris i de Recerca; AstraZeneca; Agence Nationale de la Recherche; GlaxoSmithKline","keywords":"Drug resistance; Biology; Multidrug tolerance; Drug; Phenotype; Cancer; Computational biology; Drug tolerance; Tumor microenvironment; Cancer research; Biofilm; Pharmacology; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.001021278,0.001148457,0.006574855,0.0003185473,0.0001049734,0.000100543,0.000498227,0.001582694,0.004349562],"category_scores_gemma":[0.0001780076,0.0006731576,0.003665819,0.0007660926,0.0001977913,0.00006094752,0.0002715572,0.003978932,0.0009020788],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008516501,"about_ca_system_score_gemma":0.002128473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007333624,"about_ca_topic_score_gemma":0.0006490069,"domain_scores_codex":[0.9943666,0.0006367964,0.002165043,0.001634075,0.0005240078,0.0006734926],"domain_scores_gemma":[0.9968885,0.0003174695,0.0005813965,0.001120171,0.0002388903,0.0008535323],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002194289,0.00006700093,0.000006311861,0.01620741,0.0006732609,0.00009700342,0.00005465503,1.118385e-7,7.540468e-7,0.0000274861,0.2824216,0.7004224],"study_design_scores_gemma":[0.0002260012,0.00007259527,0.000004856872,0.1055311,0.01319909,0.00002405402,0.00002878271,6.557653e-7,0.000001625035,0.000007581179,0.8802518,0.0006519372],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000008798937,0.9792072,0.00000857386,0.002661213,0.009839533,0.003239731,0.003750221,0.0001383538,0.001146379],"genre_scores_gemma":[0.000003017004,0.9686719,0.0007142472,0.007669907,0.007815502,0.002588744,0.0005273343,0.0001687437,0.01184056],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6997705,"threshold_uncertainty_score":0.9998758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.34810387242957,"score_gpt":0.5151145649566099,"score_spread":0.1670106925270399,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}